Skip to main content
. 2017 Jun 24;7:122–125. doi: 10.1016/j.conctc.2017.06.010

Fig. 1.

Fig. 1

Likelihood of participation in an influenza vaccine clinical trial for adults ≥65 years (Scenario 1), with addition of monetary incentive (Scenario 2), with additional requirement of blood draw (Scenario 3), with additional monetary incentive and reimbursement of travel (Scenario 4). Participants who answered would not for Scenario 2 or 3 were not asked subsequent questions.